Frank H.
- Country
- Germany
- Department
- Klinik fuer Augenheilkunde
Research Overview
- Phase III Double-Blind, Randomized, Placebo-Controlled Trial of Intravenous Tenecteplase for Visual Recovery in Acute Non-Arteritic Central Retinal Artery Occlusion
- Evaluation of Ranibizumab Port Delivery System Refill Regimens in Neovascular Age-Related Macular Degeneration: A Phase IIIb Randomized Study
- Phase 2 Double-Masked Placebo-Controlled Dose-Finding Study of Danicopan in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Data & Insights
Has run more than one trial at 87 of 172 partner sites.
Specializations
Age-Related Macular Degeneration
The investigator specializes in treating various forms of age-related macular degeneration (AMD), with particular emphasis on both geographic atrophy and neovascular manifestations of the condition.
- Geographic Atrophy Management
- Neovascular AMD Treatment
- Novel Drug Delivery Systems
Their work encompasses innovative therapeutic approaches including complement inhibition and sustained-release drug delivery platforms.
Retinal Vascular Disorders
The investigator focuses on acute interventions for retinal vascular occlusions, particularly addressing emergency treatment protocols for central retinal artery occlusion.
- Emergency Reperfusion Therapy
- Visual Recovery Protocols
- Early Intervention Strategies
Their expertise includes time-sensitive treatments aimed at preserving visual function in acute retinal vascular events.
Advanced Therapeutics
The investigator explores novel therapeutic modalities for retinal diseases, including innovative drug delivery systems and targeted molecular therapies.
- Intravitreal Therapeutics
- Long-term Disease Management
- Complement Pathway Inhibition
Their research involves evaluating sustained-release platforms and investigating new therapeutic compounds for retinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.